TomoTherapy and Integra Radionics Partner to Develop a Suite of Stereotactic Fixation Products for the Hi-Art(R) Treatment System

MADISON, Wis.--(BUSINESS WIRE)--TomoTherapy Incorporated (NASDAQ: TTPY) announced today that it has partnered with Integra Radionics, Inc., a subsidiary of Integra LifeSciences Holdings Corporation (NASDAQ: IART), to develop and distribute the InterFix™ radiosurgery kit. The kit includes a suite of fixation products that have been adapted for use in stereotactic procedures using the TomoTherapy® Hi·Art® treatment system. According to Del Coufal, vice president of marketing for TomoTherapy, the InterFix kit complements the Hi·Art treatment system well: “Radionics products are used in cancer centers around the world. With the InterFix kit, their head rings and fixation tools will work seamlessly with our system, adding to the clinical confidence our integrated CT guidance and helical delivery already make possible.”

Back to news